Prevalence and Incidence of Type 2 Diabetes in Iran
High prevalence and incidence of Type 2 Diabetes in the urban population of Iran, particularly in Tehran, are highlighted in various studies. The incidence rate in adults aged 20 years and above shows a concerning trend, with over 1% of the population developing Type 2 Diabetes annually. The alarming rate is estimated to affect more than 310,000 individuals each year. Research also links glucose intolerance to cardiovascular disease risk in Iranian men and women. Additionally, the impact of diabetes on cardiovascular risk and all-cause mortality is explored through the Tehran Lipid and Glucose Study, underlining the significant burden of diabetes on public health outcomes.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Prevalence and incidence of Type 2 Diabetes F.Hadaegh MD Professor of internal medicine and endocrinology Prevention of Metabolic Disorders Research Center Research Institute for Endocrine Sciences
Prevalence of Diabetes and Impaired Fasting Glucose in the adult (20-64 years) urban population of Iran
High prevalence of diabetes and abnormal glucose tolerance in adult population ( 20 years) of Tehran
Incidence rate of Type 2 diabetes in the adult population (20 years) of Tehran 20 18.7 Incident rate (per 1000 person year) 17.6 18 16 14 12 10.7 10.6 10 8 6 4.1 4 2 0 20-34 yrs 35-49 yrs 50-64 yrs 65 yrs Total Harati H, et al. BMC Pubic Health 2009
Hrati et al Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran , BMC pubic Health 2009 More than 1% of the Iranian urban population older than 20 years develops Type 2 diabetes each year. If we extrapolate the standardized annual rate of the incident diabetes to the current urban population of IRAN older than 20 years, it is estimated that each year more than 310, 000 individuals develop Type 2 diabetes. This alarming rate confirms previous estimates that the Middle East region will have the highest increase in number of diabetes cases in the following 20 years 6
Glucose intolerance and risk of cardiovascular disease in Iranian men and women: Results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study( Hadaegh et alJ. Endocrinol. Invest,32,724-730,2009) 7
Cardiovascular risk and all cause mortality attributable to diabetes: Tehran Lipid and Glucose Study Bozorgmanesh et al. j. Endocr. Inves Outcome Diabetes status New Diagnosed DM 6.3 (2.4-11.0) Known DM DM New Diagnosed DM 5.0 (1.0-9.9) Known DM DM New Diagnosed DM 6.5 (1.5-13.2) Known DM DM PAF (%) CVD 15.2 (9.7-21.1) 21.5 (14.4-28.9) CHD 15.7 (9.9-22.2) 20.8 (13.1-28.7) Mortality 17.5 (9.4-26.6) 24.0 (13.8-34.7)
